Bio

Eric Hwang advises global public and private technology and life sciences clients on diverse strategic transactions, including complex cross-border mergers and acquisitions (M&A), corporate governance matters, joint ventures, and corporate and venture capital, private equity, and corporate investments. Drawing from a background in both in-house, business-side leadership and private practice roles, Eric has a deep understanding of the type and scope of services that companies seek from outside advisors. Over the course of his career, he has completed more than 80 transactions, representing an aggregate value of more than $30 billion. Eric’s experience with strategic matters, financial analysis, and business operations allows him to quickly adjust to ever-changing situations and provide practical advice and business-minded solutions to a myriad of complex issues. Before joining Morgan Lewis, Eric was a partner in the corporate and M&A practice of another global law firm, and prior to that spent several years at an international law firm where he represented technology, pharmaceutical, and healthcare clients in M&A and other strategic transactions. Prior to reentering private practice, Eric worked first as senior counsel and then as director of corporate development at Oracle Corporation, a global enterprise technology company. In his roles at Oracle, Eric held responsibility for all aspects of the company’s acquisitions, and played a key role in the acquisitions of BEA Systems and Sun Microsystems, as well as other acquisitions of public companies. Eric was also an early and key contributor to Oracle's M&A program, establishing practices that have since been used in more than 100 acquisitions. As both a business and legal leader in Oracle's many acquisitions throughout his tenure, Eric played an important role in helping M&A become one of Oracle’s strategic drivers of growth, with annual revenue growing $19 billion from 2007 to 2012.